New Developments in the Genetics of Hypertension: What Should Clinicians Know? David S. Geller Hypertension (WB White and AJ Peixoto, Section Editors) 31 October 2015 Article: 122
Polypill: Progress and Challenges to Global Use—Update on the Trials and Policy Implementation Ruth WebsterAnthony Rodgers Public Health Policy (TA Gaziano, Section Editor) 26 October 2015 Article: 121
Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk Luca MieleValentina GiorgioAntonio Grieco Diabetes and Cardiovascular Disease (S Malik, Section Editor) 24 October 2015 Article: 120
Management of Hypertension in Patients with Ischemic Heart Disease Brian B. Agbor-EtangJohn F. Setaro Hypertension (WB White and AJ Peixoto, Section Editors) 20 October 2015 Article: 119
Atrial Fibrillation Monitoring in Cryptogenic Stroke: the Gaps Between Evidence and Practice Krittapoom AkrawinthawongKarthik Venkatesh PrasadScott Wayne Ferreira Stroke (D Wang, Section Editor) 20 October 2015 Article: 118
Radial Versus Femoral Access for Acute Coronary Syndromes Helen RoutledgeSanjay Sastry Management of Acute Coronary Syndromes (R Gulati, Section Editor) 19 October 2015 Article: 117
Renal Denervation: Where to Now? Neil J. WimmerLaura Mauri New Therapies for Cardiovascular Disease (KW Mahaffey, Section Editor) 19 October 2015 Article: 116
Healthcare Professional Shortage and Task-Shifting to Prevent Cardiovascular Disease: Implications for Low- and Middle-Income Countries Lungiswa Primrose TsolekileShafika Abrahams-GesselThandi Puoane Public Health Policy (TA Gaziano, Section Editor) 19 October 2015 Article: 115
Coagulopathy in Mechanical Circulatory Support: A Fine Balance Julie L. RosenthalRandall C. Starling Heart Failure (MR Mehra and E Joyce, Section Editors) 19 October 2015 Article: 114
Implantable Hemodynamic Monitoring in Ambulatory Heart Failure: Who, When, Why, How? Akshay S. Desai Heart Failure (MR Mehra and E Joyce, Section Editors) 19 October 2015 Article: 113
Mindfulness and Cardiovascular Disease Risk: State of the Evidence, Plausible Mechanisms, and Theoretical Framework Eric B. LoucksZev Schuman-OlivierCarl Fulwiler Psychological Aspects of Cardiovascular Diseases (A Steptoe, Section Editor) 19 October 2015 Article: 112
Psychological Aspects of Cardiac Care and Rehabilitation: Time to Wake Up to Sleep? Jonathan GallagherGiulia ParentiFrank Doyle Psychological Aspects of Cardiovascular Diseases (A Steptoe, Section Editor) 19 October 2015 Article: 111
Risk Stratification for Primary Prevention of Coronary Artery Disease: Roles of C-Reactive Protein and Coronary Artery Calcium Waqas T. QureshiJamal S. RanaMouaz H. Al-Mallah Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor) 19 October 2015 Article: 110
New Approaches in Detection and Treatment of Familial Hypercholesterolemia Merel L. HartgersKausik K. RayG. Kees Hovingh Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor) Open access 19 October 2015 Article: 109
Management of Hypertension in Obstructive Sleep Apnea Sofia F. FurlanCaio V. BrazLuciano F. Drager Hypertension (WB White and AJ Peixoto, Section Editors) 19 October 2015 Article: 108
Management of Hypertension in Children and Adolescents Joshua SamuelsCynthia BellRita Swinford Hypertension (WB White and AJ Peixoto, Section Editors) 19 October 2015 Article: 107
Diagnosis and Management of Thoracic Aortic Disease David M. DudzinskiEric M. Isselbacher Peripheral Vascular Disease (MR Jaff, Section Editor) 15 October 2015 Article: 106